News
KENYA SET TO MANUFACTURE NEW ONCE-MONTHLY HIV PREVENTION PILL
Kenya's Universal Corporation is among seven generic makers licensed by Merck to prepare production of alimatravir, an experimental once-monthly HIV prevention pill still in Phase 3 trials and not yet approved for public use.
By Anne Moses
10 hours ago